WT
CSBR icon

Whittier Trust’s Champions Oncology CSBR Stock Holding History

Whittier Trust’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-800
Closed -$5.29K – 1358
2025
Q4 		$5.29K Hold
800
– – ﹤0.01% 1222
2025
Q3 		$5.04K Buy
+800
New +$5.64K ﹤0.01% 1226

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whittier Trust's CSBR Position: Q1 2026 in Review

Whittier Trust sold out of Champions Oncology (CSBR) in Q1 2026, closing a stake of 800 shares — an estimated $5.29K sold.

Whittier Trust first reported a position in CSBR in Q3 2025 and held it in 2 quarters. The position peaked at $5.29K in Q4 2025. 25 funds tracked by Wall St. Rank hold CSBR as of Q1 2026.

  • Whittier Trust reported no remaining Champions Oncology position as of Q1 2026 after selling out during the quarter.
  • Whittier Trust sold 800 Champions Oncology shares in Q1 2026, an estimated $5.29K.
  • Whittier Trust first reported a position in Champions Oncology in Q3 2025 and held it in 2 quarters.
  • Whittier Trust's Champions Oncology position peaked at $5.29K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2026.

Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.